Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04568681 · ClinicalTrials.gov registry record

Deep Brain Stimulation Effects in Dystonia

A clinical trial, sponsored by University of Florida.

Completed
Registry status
7
Enrollment target

NCT04568681 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04568681 has completed, sponsored by University of Florida.

COMPLETED
Registry status
7 participants
Enrollment target

Study Summary

Deep Brain Stimulation (DBS) is an effective therapy for patients with medically refractory primary dystonia. However, DBS programming for dystonia is not standardized and multiple clinic visits are frequently required to adequately control symptoms. We aim to longitudinally record brain signals from patients using a novel neurostimulator that can record brain signals. We will correlate brain signals to clinical severity scores to identify pathological rhythms in the absence of DBS, and we will study the effects of DBS on these signals in order to guide clinical programming. We are going to recruit patients who receive the Medtronic Percept device, which allows for brain signal recordings (this feature is FDA approved). The investigators will be conducting an observational study using this device to collect data that the subjects receive as standard of care.

Interventions

  • DEVICE Deep brain stimulation (DBS)

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2020-11-05
Est. Completion 2022-07-12

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT04568681

The ClinicalTrials.gov registry entry for NCT04568681 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Deep brain stimulation (DBS) is the first listed.

NCT04568681 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04568681 about?

NCT04568681 is a clinical study titled "Deep Brain Stimulation Effects in Dystonia". Deep Brain Stimulation (DBS) is an effective therapy for patients with medically refractory primary dystonia. However, DBS programming for dystonia is not standardized and multiple clinic visits are frequently required to adequately control symptoms. We aim to longitudinally record brain signals fro...

What is the current status of trial NCT04568681?

This trial is currently completed. The enrollment target is 7 participants. The study started on 2020-11-05. Estimated completion is 2022-07-12.

What interventions are being tested in trial NCT04568681?

The interventions under investigation include: Deep brain stimulation (DBS) (DEVICE).

Who is sponsoring clinical trial NCT04568681?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.